Beyond pain relief: rethinking sleep outcomes in CGRP-targeted migraine therapy
Аннотация
Publication date: December 2026 Source: Sleep Medicine Reviews, Volume 90 Author(s): Marc Daou, Joyce K. Lee-Iannotti, Jennifer Robblee
Publication date: December 2026 Source: Sleep Medicine Reviews, Volume 90 Author(s): Marc Daou, Joyce K. Lee-Iannotti, Jennifer Robblee
Comprehensive Physiology, Volume 16, Issue 6, December 2026.
Physiological Reports, Volume 14, Issue 22, November 2026.
Comprehensive Physiology, Volume 16, Issue 6, December 2026.
ABSTRACT Introduction/Aims Pompe disease is a genetic myopathy caused by acid alpha‐glucosidase enzyme deficiency. Treatment response is mainly evaluated using motor scores, for instance the 6‐min walk test (6MWT) or the Motor Function...
ABSTRACT Introduction/Aims Inflammatory neuropathies (IN), such as Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), are characterized by peripheral nerve injury driven by immune...